Price of Baraclude to be reduced

Published: 2008-01-10 06:56:00

Updated: 2008-01-10 06:56:00

The Ministry of Health and Welfare says health insurance price of BMS Korea's Baraclude (entecavir) will be reduced based on the guideline of the Korean Association for the Study of the Liver and clinical period, while the treatment period will be extended from one year to three years.

Price o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK